GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CB Scientific Inc (OTCPK:CBSC) » Definitions » Other Current Payables

CB Scientific (CB Scientific) Other Current Payables : $0.00 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CB Scientific Other Current Payables?

CB Scientific's Other Current Payables for the quarter that ended in Dec. 2023 was $0.00 Mil.


CB Scientific Other Current Payables Historical Data

The historical data trend for CB Scientific's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CB Scientific Other Current Payables Chart

CB Scientific Annual Data
Trend Mar21 Mar22 Mar23
Other Current Payables
- - -

CB Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CB Scientific Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


CB Scientific Other Current Payables Related Terms

Thank you for viewing the detailed overview of CB Scientific's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


CB Scientific (CB Scientific) Business Description

Traded in Other Exchanges
N/A
Address
10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135
CB Scientific Inc through its U.S. and international subsidiaries provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.